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Background: Infections in newborns remain one of the most significant problems in modern medicine. Escherichia
coli is an important cause of neonatal bloodstream and respiratory tract infections and is associated with high
mortality. The aim of our study was to investigate the epidemiology of E. coli infection in Polish neonatal intensive
care units (NICUs) and resistance to antibiotics, with particular reference to the safety of very low birth weight
infants.
Methods: Continuous prospective infection surveillance was conducted in 2009–2012 in five NICUs, including 1,768
newborns whose birth weight was <1.5 kg. Escherichia coli isolates from different diagnostic specimens including
blood, tracheal/bronchial secretions and others were collected. All isolates were tested using disk diffusion
antimicrobial susceptibility methods. Pulsed-field gel electrophoresis was used to determine the possible horizontal
transfer of E. coli among patients.
Results: The incidence of E. coli infections was 5.4% and 2.0/1,000 patient-days. The occurrence of E. coli infections
depended significantly on the NICU and varied between 3.9% and 17.9%. Multivariate analysis that took into
account the combined effect of demographic data (gender, gestational age and birth weight) and place of birth
showed that only the place of hospitalisation had a significant effect on the E. coli infection risk. The highest levels
of resistance among all E. coli isolates were observed against ampicillin (88.8%) and amoxicillin/clavulanic acid
(62.2%). Among E. coli isolates, 17.7% were classified as multidrug resistant. Escherichia coli isolates showed different
pulsotypes and dominant epidemic clones were not detected.
Conclusions: Our data indicate that antibiotic prophylaxis in the presence of symptoms such as chorioamnionitis
and premature rupture of membranes did not help reduce the risk of E. coli infection. Multivariate analysis
demonstrated only one significant risk factor for E. coli infection among infants with a birth weight <1.5 kg, that is,
the impact of the NICU, it means that both neonatal care and care during pregnancy and labour were found to be
significant.
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Infections in newborns, particularly those with very low
birth weight of <1.5 kg, remain one of the most signifi-
cant problems in modern medicine. Escherichia coli is
an important cause of neonatal bloodstream and respira-
tory tract infections and is associated with high mortality
[1,2].
In late-onset infection, E. coli may be acquired from
the mother or the environment and may enter the
bloodstream from the urinary or gastrointestinal tract
[3]. Several studies have demonstrated a high rate of
transmission of E. coli within families and households
[4,5]. Escherichia coli species comprise commensal
strains, intestinal pathogenic strains and others that
cause infections outside the gastrointestinal system, such
as extra-intestinal pathogenic E. coli. Extra-intestinal
infections due to E. coli are common in all age groups
and include bacteremia, urinary tract infection, meningi-
tis (mostly in neonates), nosocomial pneumonia and
others [6].
Cephalosporin, fluoroquinolone and trimethoprim-
sulfamethoxazole are widely used to treat infections
caused by E. coli and resistance to these agents is re-
sponsible for treatment failure [7]. The development of
multidrug resistance (MDR) among E. coli isolates is also
of concern [8].
Enterobacteriaceae-producing extended-spectrum β-
lactamases (ESBLs) have emerged as serious pathogens
in hospitals and have been increasingly implicated in
nosocomial outbreaks in neonatal intensive care units
(NICUs). They have important therapeutic implications
as they exhibit resistance to several antimicrobial agents,
including third-generation cephalosporins, extended-
spectrum penicillin and monobactam. Carbapenems and
cephamycins represent the only classes of antibiotics
active against ESBLs [9].
Escherichia coli has been reported as one of the major
causes of neonatal infections that may cause high mor-
bidity and mortality [10]. Potential risk factors of E. coli
neonatal infections have also been analysed.
Considering the increasing antimicrobial resistance
and mortality in NICUs, there is an urgent need to
understand the epidemiology and risk factors of E. coli
infections. Therefore, the aim of our study was to
investigate the epidemiology of infections caused by E.
coli in five Polish NICUs, resistance to antibiotics and
potential risk factors that may contribute to such in-
fections (E. coli infections were compared with infec-
tions caused by other bacteria). We also considered
the possibility of using data on E. coli infection in
assessing the quality of perinatal care. All these data
may contribute to infection prevention and better con-
trol, and the routes of transmission of E. coli were also
evaluated.Methods
Ethics
The Polish Neonatal Surveillance Network (PNSN),
whose director is Prof. Ewa Helwich from the Institute of
Mother and Child in Warsaw, covered six Neonatal
Clinics within the territory of Poland: Clinic of Neonat-
ology and Intensive Neonatal Care, Institute of Mother
and Child, Warsaw, Clinic of Neonatology, Jagiellonian
University Medical College, Krakow, Clinic of Neonat-
ology and Intensive Neonatal Care, Warsaw Medical
University, Warsaw, Clinic of Neonatology, Polish
Mothers’ Memorial Hospital-Research Institute, Lodz,
Department of Neonatal Diseases, Pomeranian Medical
University, Szczecin and Gynaecology and Obstetrics
Hospital Medical University Poznan. The Polish Neo-
natal Surveillance Network was established on 6th of
September 2007 (Agreement; see attachment). The Chair
of Microbiology cooperated within the program of the
PNSN. Utilization of data collected in the PNSN for
scientific purposes was approved by the Bioethics Com-
mittee of Jagiellonian University Medical College (Chair-
person Prof. Piotr Thor) – no. KBET/221/B/2011 ) on 27
October 2011 (Appropoval; see attachement). All data
entered into the electronic database and analysed during
this study were previously anonymised and de-identified.
Study population
A prospective surveillance of infections was conducted
between 1 January 2009 and 31 December 2012 in five
from six NICUs that participated in the activities of the
PNSN.
The study covered 1,768 newborns. All episodes of in-
fection were subjected to registration, regardless of the
time of occurrence of the first symptoms. Case patients
were defined according to Gastmeier et al. [11], with
modifications for neonates with birth weight <1.5 kg.
Early-onset infection (EOI) was defined as infection di-
agnosed within 3 days of delivery. The occurrence of
chorioamnionitis was based on clinical data (all cases)
and histopathology examination of the placenta (~65%
of cases).
Bacterial isolates
Various diagnostic specimens including blood, and tra-
cheal/bronchial secretions were collected for culture and
assessment of the microbial aetiology of infections.
Altogether, 96 E. coli strains were isolated, and the
present study covered 90 isolates (six were not stored).
Isolates were identified by the automated identification
system (VITEK 2; bioMérieux, Warsaw, Poland). Isolates
from other infections were also analysed. Aetiological
factors of other infections were: other Gram-negative
bacteria, Gram-positive bacteria, atypical bacteria and
yeast.
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All isolates were tested using disk diffusion antimicrobial
susceptibility methods on Mueller–Hinton agar plates
according to the current EUCAST guidelines (European
Committee on Antimicrobial Susceptibility Testing.
Clinical breakpoint tables v. 3.1; http://www.eucast.org
v.3.1, accessed: 11.02.2013). ESBL activity was detected
with a modified double disk synergy test using a com-
bination of cefotaxime, ceftazidime, cefepime and aztre-
onam discs, placed 20 mm apart around the disc
containing amoxicillin/clavulanic acid [12].
Pulsed-field gel electrophoresis (PFGE)
PFGE was used to determine the possible horizontal
transfer of E. coli strains among patients. All isolates
were analysed using the standardized PFGE protocol
developed at the Centers for Disease Control and
Prevention by the PulseNet program ttp://www.cdc.gov/
pulsenet/pathogens/ecoli.html (accessed: 11.02.2013).
Genomic DNA was digested with 10 U XbaI (Thermo-
Scientific, ABO, Gdansk, Poland). The resulting DNA
fingerprinting was analysed using the CHEF III PFGE
system (BioRad, Warsaw, Poland) in 0.5 Tris–borate–
EDTA buffer at 14°C at 6 V for 20 h with a ramped pulse
time of 2.2–54.2 s. The GelCompar (Applied Maths) was
used for cluster analysis using the Dice coefficient and
the unweighted pair group method with arithmetic mean.
Risk factors
Several potential risk factors were compared according
to infections caused by E. coli and by other strains: birth
weight, gestational age, CRIB, Apgar score, sex, type of
birth, feeding patterns (breastfeeding, trophic feeding, or
parenteral nutrition), perinatal antibiotic prophylaxis,
prolonged premature rupture of membranes (PROM).
Statistical analysis
The influence of type of care and sociodemographic
characteristics on the epidemiology of E. coli/other in-
fection was analysed with several statistical techniques,
depending on type and distribution of analysed variables.
The relation between probability of E. coli and continu-
ous parameters (age, length of stay) was based on simple
analysis of variance (ANOVA). If the distribution of con-
tinuous variables significantly differed from normality,
the nonparametric alternative to ANOVA, the Kruskal–
Wallis test, was used. For the contingency of nominal
characters frequency test: Pearson’s chi-square (χ2) and
likelihood ratio was used. The common influence of risk
factors on E. coli identification was analysed with a gen-
eralised linear model. Because of the categorical charac-
ter of the effect and combined — numerical as well as
categorical — types of the predictors, the model was
constructed for binominal distribution of dependentvariables and logit-linked function. A p value <0.05 was
considered significant. All analyses were performed using
JMP version 9.3 (SAS Institute Inc., Cary, NC, USA).
Results
Non-E. coli infections
Neonates with infections of non-E. coli aetiology were
characterised by better general condition at birth
(Table 1) than neonates with E. coli infections. Signifi-
cantly fewer infants had adverse perinatal outcomes,
such as PROM or chorioamnionitis, while significantly
more newborns were delivered by caesarean section.
The fatality rate of newborns with non-E. coli infections
was two times lower than in those with E. coli infections.
Escherichia coli infections
The incidence of E. coli infections was 5.4% and 2.0/
1,000 patient-days. EOIs accounted for 12.2% of all in-
fections and late-onset infections (LOIs) accounted for
10.5%. The incidence of EOIs was 1.7% and LOIs was
3.7%. The occurrence of E. coli infections (both EOI and
LOI) depended significantly on the NICU (χ2 = 73,836;
p < 0.0001) and varied between 3.9% and 17.9%. The
most common E. coli infection was pneumonia (53.1%)
and bloodstream infection (40.6%). Escherichia coli in-
fections were diagnosed at day 17 on average (median:
12 days).
The mean length of hospitalisation (from birth to dis-
charge, or until a weight of 1.8 kg was reached) of new-
borns with non-E. coli infections was significantly
shorter: 48 versus 55 days (infants with E. coli infection).
The gestational age and birth weight of newborns with
E. coli infections were lower than in those without infec-
tion or with other infections (Table 1). The other risk fac-
tors of E. coli infections were: low Apgar 1 and Apgar 5
scores, total parenteral nutrition, chorioamnionitis, or
PROM diagnosed during pregnancy or delivery (Table 1).
Caesarean section reduced the risk of E. coli infection,
although perinatal antibiotic prophylaxis (PAP) (no stan-
dardised protocol) did not reduce the risk of infection;
that is, despite the use of PAP, E. coli infections were
observed significantly more frequently (Table 1).
Multivariate analysis
Multivariate analysis that took into account the com-
bined effect of intrapartum antibiotic prophylaxis (IAP),
PROM, chorioamnionitis and delivery mode (caesarean
section) showed no significant effect on the risk of E.
coli infection for factors other than the mode of delivery.
However, multivariate analysis that took into account
the combined effect of demographic data (sex, gesta-
tional age and birth weight) and place of birth (NICU)
showed that only the place of hospitalisation had a
significant effect on E. coli infection risk.
Table 1 The characteristics of newborns with symptoms of infections and E. coli infections
Infants without
infections [N = 890]
Infants with other
infections [N = 782]
OR 95% CI P*-value Infants with
E. coli-infections [N = 96]
OR 95% CI P**-value
Risk factors Average 95% CI Average 95% CI Average 95% CI
Birth weight 1091.4 [1072.4, 1110.4] 991.1 [971.9,1010.2] NA <0.0001 909.1 [858.6, 959.6] NA <0.0001
Gestational age 29.1 [28.8, 29.3] 28.0 [27.8, 28.2] NA <0.0001 27.0 [26.5, 27.6] NA <0.0001
CRIB 4.5 [4.1, 5.0] 4.4 [4.0, 4.8] NA - 5.5 [4.1, 6.8] NA -
Apgar (1 min.) 5.5 [5.3, 5.6] 5.3 [5.2, 5.4] NA <0.0001 4.8 [4.4, 5.2] NA <0.0001
Apgar (5 min.) 6.0 [5.9, 6.2] 6.0 [5.9, 6.2] NA - 5.7 [5.3, 6.1] NA <0.0001
Number and percentage of population
Female gender 438 49.2 350 44.8 1.19 0.986-1.45 - 44 45.8 0.96 0.626-1.465 -
Caesarean section 731 82.1 624 79.8 1.03 0.803-1.326 0.0002 62 64.6 2.17 1.377-3.408 <0.0001
Breast feeding 64 7.2 44 5.6 1.29 0.874-.932 - 3 3.1 5482 0.563-6.071 -
Trophic feeding 295 33.1 310 39.6 0.75 0.618-0.922 0.008 42 43.8 0.84 0.550-1.295 <0.0001
Total parenteral nutrition 319 35.8 409 52.3 0.51 0.419-0.619 <0.0001 56 58.3 0.78 0.509-1.203 <0.0001
Perinatal antibiotic prophylaxis 335 37.6 344 44.0 0.77 0.632-0.935 0.009 46 47.9 0.85 0.558-1.305 <0.0001
Death of the patient 209 23.5 64 8.2 3.44 2.553-4.643 <0.0001 14 14.6 0.52 0.280-0.972 <0.0001
Infants born from deliveries where the following were diagnosed during the mother’s pregnancy:
PROM 185 20.8 211 27.0 0.71 0.566-0.890 0.0008 33 34.4 0.71 0.449-1.106 <0.0001
Chorioamnionitis 62 7.0 60 7.7 0.90 0.623-1.303 - 13 13.5 0.53 0.279-1.000 <0.0001
P* value: analysis of infants without infection versus those with non-E. coli infections.
P** value: analysis of infants with non-E. coli infections versus infants with E. coli infections.
CRIB, clinical risk index for babies.
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on IAP, PROM, amniotic inflammation, type of labour,
gestational age, NICU and the likelihood of specific E.
coli infections (vs. other infections) showed a significant
statistical relationship with the complete model.
Escherichia coli resistance and similarity of strains
Analysis of the isolates showed that the highest levels of
resistance among all E. coli isolates were observed
against ampicillin (88.8%) and amoxicillin/clavulanic acid
(62.2%), trimethoprim/sulfamethoxazole (34.4%) and
aztreonam (33.3%). The ESBL phenotype was found
among 25 isolates (27.7%). Sixteen of the ESBL-positive
strains (17.7%) were also reported as resistant to at least
two other groups of antibiotics (fluoroquinolones, ami-
noglycosides or trimethoprim–sulfamethoxazole), which
allows us to consider these strains as MDR organisms
(Table 2).
Resistance to ampicillin (p = 0.0375), amoxicillin/clavu-
lanic acid, ceftazidime, cefotaxime, cefuroxime, cefepime,Table 2 Characteristics of ESBL-positive strains
Isolate Site of isolation Resistance profile
114 Respiratory tract Amp, Amc, Fep, Cxm,
120 Respiratory tract Amp, Amc, Fep, Caz, C
124 Respiratory tract Amp, Amc, Fep, Caz, C
4S Respiratory tract Amp, Amc, Fep, Caz, C
110S Rectum Amp, Amc, Caz, Ctx, Cx
227 Respiratory tract Amp, Amc, Fep, Ctx, C
197 Amniotic fluid Amp, Amc, Fep, Ctx, C
226 Blood Amp, Amc, Fep, Caz, C
7 Respiratory tract Amp, Amc, Fep, Caz, C
13 Respiratory tract Amp, Amc, Ctx, Cxm, A
118 Respiratory tract Amp, Amc, Caz, Ctx, Cx
159 Respiratory tract Amp, Amc, Caz, Ctx, Cx
160 Respiratory tract Amp, Amc, Caz, Ctx, Cx
105S Respiratory tract Amp, Amc, Ctx, Cxm, A
24 W Rectum Amp, Amc, Fep, Caz, C
32 W Rectum Amp, Amc, Fep, Ctx, C
14 Blood Amp, Amc, Fep, Caz, C
62 Blood Amp, Amc, Fep, Caz, C
166 Blood Amp, Amc, Caz, Ctx, Cx
205 Blood Amp, Amc, Fep, Caz, C
3 W Blood Amp, Fep, Caz, Ctx, Cx
9 Urine Amp, Amc, Fep, Ctx, C
15 Urine Amp, Amc, Fep, Ctx, C
42 Respiratory tract Amp, Amc, Fep, Caz, C
112 Respiratory tract Amp, Amc, Fep, Ctx, C
Amp, ampicillin; Amc, amoxicillin/clavulanic acid; Fep, cefepime; Ctx, cefotaxime; Ca
Tob, tobramycin; Ak, amikacin; Cn, gentamicin; Sxt, trimethoprim/sulfamethoxazole;aztreonam (all p-values <0.0001), amikacin (p = 0.0012),
gentamicin (p = 0.0016), tobramycin (p < 0.0001), tri-
methoprim/sulfamethoxazole (p = 0.0016) and ciproflox-
acin (p < 0.0001) in a group of ESBL-positive strains was
significantly higher than in ESBL-negative strains. Only
five of the studied isolates studies were resistant to one
of four tested carbapenems; three of these isolates be-
long to non-ESBL strains. Almost all E. coli strains
(97.8%) were susceptible to tigecycline and piperacillin/
tazobactam.
Escherichia coli isolates showed that different pulso-
types and dominant epidemic clones were not detected.
Cluster analysis based on PFGE of the 90 isolates
showed 71 unique types, some of which were <70%
similar, suggesting a genotypically variable population
(Figure 1). Isolates that have identical pulsotypes usually
were derived from the same patient (as in the case of 11
isolates) or were isolated from different patients of the
same NICU in the same period of time (in the case of
seven isolates). The location of the NICU and the site ofMDR organism (yes/no)
Atm, Tob, Cn, Sxt, C Yes
tx, Cxm, Atm, Sxt, Cip, C Yes
tx, Cxm, Atm, Tob, Cn, Sxt, Cip, C Yes
tx, Cxm, Atm, Tob, Cn, Ak No
m, Atm, Dor No
xm, Atm No
xm, Atm No
tx, Cxm, Atm, Tob, Sxt, Cip Yes
tx, Cxm, Atm, Tob No
tm No
m, Atm, Tob, Sxt, Cip Yes
m, Atm, Tob, Cn, Sxt, Cip,Tzp Yes
m, Atm, Tob, Cn, Sxt, Cip,Tzp Yes
tm, Tob, Cn, Ak, Sxt Yes
tx, Cxm, Atm, Ak, Sxt, Cip Yes
xm, Atm, Tob, Cn, Ak, Sxt Yes
tx, Cxm, Atm, Tob, Cip Yes
tx, Cxm, Atm, Tob, Ak, Sxt, Cip Yes
m, Atm, Tob, Sxt, Cip Yes
tx, Cxm, Atm, Tob, Sxt, Cip Yes
m, Atm, Tob, Cn, Ak No
xm, Atm No
xm, Atm No
tx, Cxm, Atm, Tob, Ak, Sxt, Cip Yes
xm, Dor, Atm, Sxt, C Yes
z, ceftazidime; Cxm, cefuroxime; Dor, doripenem; Atm, aztreonam;
C, chloramphenicol; Cip, ciprofloxacin; Tzp, piperacillin/tazobactam.
Figure 1 Results of PFGE typing of E. coli isolates.
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cluster analysis.
Discussion
Infections in newborns, particularly those with very low
and extremely low birth weights of <1.5 kg, are a signifi-
cant problem. Escherichia coli is responsible for a smaller
fraction of neonatal infections than other microorgan-
isms, but it is associated with the highest mortality [13].
Data collected by the European Antimicrobial Resist-
ance Surveillance Network confirm that in Europe from
2002 to 2009 the occurrence of E. coli in bloodstream
infections increased by more (71%) than Staphylococcus
aureus (34%), which indicates the growing importance of
E. coli in the epidemiology of infections [14] and the
need for detailed molecular studies of these strains.
Our study was performed to characterise the population
of E. coli isolated from neonatal infections; mainly from
pneumonia and bloodstream infections from Polish
NICUs.
According to other data, E. coli causes about 9% of
infections [15] or 5–13% of LOI in NICUs [15-17]. Add-
itionally, in Polish NICUs, E. coli was the most frequently
isolated pathogen in early-onset PNSN infections [18]. In
recent years, E. coli infections in NICUs have become
more prevalent, and it is believed that this is mainly
owing to the implementation of PAP [19-21].
Other studies on E. coli have identified that low gesta-
tional age [22], duration of hospital stay [23] and use of
antibiotics [24-26] are the risk factors of colonisation
and infection among newborns. Our results support
these data, and we hypothesise that another major risk
factor may be maternal colonisation. According to
Denkel et al., colonised mothers may be an important
reservoir of E. coli and significant risk factors for E. coli
colonisation, and consequently, E. coli infections of very
low birth weight infants [27].
Unfortunately, screening of mothers was not per-
formed in NICUs of PNSN, but our PFGE results support
our hypothesis: the population of E. coli was divergent
and no epidemic clones were identified. That is totally
different than for other species such as methicillin-
resistant S. aureus or Klebsiella pneumoniae [28].
The mode of delivery seems to be a protective factor
against E. coli infections and also supports the hypoth-
esis on maternal–neonatal transmission. About 17.9% of
neonates without infections were born vaginally, com-
pared with 35.4% of those with E. coli infection. The va-
gina is a significant reservoir of E. coli, which can be
critical in vertical transmission of E. coli infection. Our
results indicate that perinatal factors and vaginal trans-
mission may also significantly affect the epidemiology of
E. coli infection, including LOI, which could be import-
ant for control of hospital-acquired infections.In our study, the fatality rate of E. coli infections was
almost twice as high as that of infections of other aeti-
ology. The reason for this was mainly the high patho-
genicity of E. coli: the majority of tested strains belonged
to one of two virulence groups (B2, 68.9%, or D, 17.8%)
[6,29]. Isolates from the B2 group had significantly more
virulence genes than isolates from other groups; in par-
ticular, fimH, sfa, ireA, fhuA, fyuA and fepA genes were
more likely to occur [29]. Similarly, 36.6% of strains
belonged to the ST131 clone and showed a high level of
virulence and resistance, which could play an important
role in the epidemiological success of this sequence type.
Clonal group ST131 contained slightly more than one-
third of the studied isolates and had a link to ESBL
production [29].
Among ESBL-positive isolates, which accounted for
27.7% of all isolates, higher levels of resistance to amino-
glycosides and also ciprofloxacin and trimethoprim-sulfa-
methoxazole were observed compared with non-ESBL
isolates. The higher level of resistance may contribute to
the fact that such resistance is localised mainly on plas-
mids and may be easily transferred not only among E.
coli isolates, but also among isolates belonging to other
species. Using of one of the antibiotics (β-lactam, amino-
glycoside, or fluoroquinolones) may lead to the co-
selection of fluoroquinolone resistance by β-lactams or
aminoglycosides, and vice versa β-lactams or aminogly-
coside resistance by fluoroquinolones [30].
Conclusions
Our study showed that there are some risk factors that
should be considered during perinatal care. Routine
screening of mothers and newborns for E. coli should be
implemented in maternity care to decrease morbidity
and mortality. Pre-partum hospitalisation for premature
labour should be an indication for screening by rectal
swabs, prenatally and on the day of birth. Unfortunately,
the presented data indicate that PAP in the presence of
symptoms such as chorioamnionitis and PROM did not
help to reduce the risk of E. coli infections. Multivariate
analysis demonstrated only one significant risk factor for
E. coli infection among infants with a birth weight <1.5 kg,
namely, the impact of the NICU.
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